Dimensional Fund Advisors LP Travere Therapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$7.18 - $9.82 $5,040 - $6,893	702 Added 1.25%	56,681 $437,000
Q4 2023 Feb 07, 2024	BUY	$5.44 - $9.5 $146 - $256	27 Added 0.05%	55,979 $503,000
Q3 2023 Nov 09, 2023	BUY	$7.64 - $17.25 $15,577 - $35,172	2,039 Added 3.78%	55,952 $500,000
Q2 2023 Aug 09, 2023	SELL	$15.3 - $22.61 $4,039 - $5,969	-264 Reduced 0.49%	53,913 $828,000
Q1 2023 May 12, 2023	SELL	$17.82 - $22.89 $880,664 - $1.13 Million	-49,420 Reduced 47.7%	54,177 $1.22 Million
Q4 2022 Feb 09, 2023	SELL	$18.47 - $26.14 $7.88 Million - $11.1 Million	-426,494 Reduced 80.46%	103,597 $2.18 Million
Q3 2022 Nov 10, 2022	SELL	$22.91 - $28.63 $7.65 Million - $9.56 Million	-333,969 Reduced 38.65%	530,091 $13.1 Million
Q2 2022 Aug 12, 2022	SELL	$20.94 - $30.01 $4.92 Million - $7.05 Million	-234,998 Reduced 21.38%	864,060 $20.9 Million
Q1 2022 May 13, 2022	BUY	$23.61 - $30.6 $957,503 - $1.24 Million	40,555 Added 3.83%	1,099,058 $28.3 Million
Q4 2021 Feb 09, 2022	BUY	$24.34 - $31.17 $2.14 Million - $2.74 Million	88,033 Added 9.07%	1,058,503 $32.9 Million
Q3 2021 Nov 12, 2021	SELL	$12.98 - $25.03 $2.29 Million - $4.41 Million	-176,356 Reduced 15.38%	970,470 $23.5 Million
Q2 2021 Aug 12, 2021	SELL	$14.11 - $26.4 $1.19 Million - $2.24 Million	-84,684 Reduced 6.88%	1,146,826 $16.7 Million
Q1 2021 May 14, 2021	BUY	$23.37 - $31.77 $930,079 - $1.26 Million	39,798 Added 3.34%	1,231,510 $30.7 Million
Q4 2020 Feb 25, 2021	BUY	$19.17 - $27.87 $22.8 Million - $33.2 Million	1,191,712 New	1,191,712 $32.5 Million

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.